PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsDNA difference between stem cell types found

BioNews

DNA difference between stem cell types found

Published 1 April 2010 posted in News and appears in BioNews 553

Author

Dr Rachael Panizzo

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.

Researchers at the Massachusetts General Hospital Cancer Center and Center for Regenerative Medicine have pinpointed key genetic differences between mouse embryonic stem cells (ES cells) and induced pluripotent stem cells (iPS cells)....

Researchers at the Massachusetts General Hospital Cancer Center and Center for Regenerative Medicine have pinpointed key genetic differences between mouse embryonic stem cells (ES cells) and induced pluripotent stem cells (iPS cells), which might help to explain the lower efficiency and robustness of iPS cells compared to ES cells.

Both ES and iPS cells are 'pluripotent' - they can self-replicate and generate all forms of tissue in the body - but the two cell types originate from different sources. ES cells are derived from early stage embryos, whereas iPS cells are reprogrammed into an ES cell-like state from adult tissue, such as skin or blood cells.

In a presentation at the New York Academy of Sciences on 23 March, and later reported in Nature News, Matthias Stadtfeld described that iPS cells were less efficient at incorporating into chimeric mice than ES cells, an experiment which tests a cell's pluripotency. The researchers, led by Dr Konrad Hochedlinger of  Harvard University Department of Stem Cell and Regenerative Biology, also found that gene activity on chromosome 12 was significantly different between the two cell types. Several microRNA sequence - small molecules which affect the activity of target genes - were activated in ES cells but silenced in iPS cells in a section of DNA on the long arm of chromosome 12. Dr Stadtfeld pointed out that this region of chromosome 12 is also silenced in mouse sperm cells and therefore that the process of reprogramming adult cells into iPS cells may have similarities to the silencing process in sperm cells.

Sheng Ding, from the Scripps Research Institute in California, commented, 'this is an important step towards identifying the differences that may exist in those imperfectly reprogrammed cells'.

IPS cells are reprogrammed by modifying four key genes using retroviruses, turning them into an embryo-like state. They are known to be more fragile, slower to divide and less efficient in generating specialised cells, like neurons, than ES cells. Scientists have also previously found genetic differences between the two cells types, however, because of their different origins, it has been difficult to determine whether these differences are due to the source, or to intrinsic differences between the cell types. To overcome this uncertainty, the researchers derived iPS and ES cells with identical genomes.

Dr Hochedlinger and his team are now investigating whether similar differences to those found in mice iPS cells are also present in human iPS cells, in order to identify the most robust iPS cell lines.

Matthias Stadtfeld said, 'it points towards the possibility that hot spots for epigenetic abnormalities exist also in human iPS cells. A profound abnormality like that could confound results obtained with patient-specific iPS cells.'

Related Articles

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
27 September 2012 • 2 minutes read

Stem cell lines show high genetic variation, study finds

by Julianna Photopoulos

An international team of researchers have found that both embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) show higher genetic abnormalities than other cells....

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
22 February 2010 • 2 minutes read

Fresh fears over the promise of iPS cells

by Dr Sophie Pryor

A new study has cast doubt over how useful human induced pluripotent stem (iPS) cells could be for research and the treatment of degenerative disease...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
4 December 2009 • 1 minute read

Adult tissue reprogrammed into stem cells faster

by Dr Rachael Panizzo

Researchers at the US Massachusetts Institute of Technology (MIT), lead by Professor Rudolf Jaenisch, have identified genetic pathways that can speed up the process of reprogramming mature adult cells into stem cells, known as induced pluripotent stem cells (iPS cells)....

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
27 July 2009 • 2 minutes read

iPS stem cells repair damaged mouse hearts

by Dr Will Fletcher

Induced pluripotent stem (iPS) cells have been used to repair damaged heart tissue in mice by a team from the Mayo Clinic in Rochester, Minnesota, US. iPS cells are adult cells that are reprogrammed to act like embryonic stem cells - in this case the iPS cells were derived from ordinary fibroblasts (cells that contribute to scars such as those resulting from a heart attack). When the cells were injected into mice whose hearts had been damaged by a heart attack they improved both...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« US judge overturns gene patents

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Common virus may be cause of recent hepatitis cases in children

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

1 August 2022 • 2 minutes read

CRISPR genome editing treatments may raise cancer risk

1 August 2022 • 2 minutes read

Differences in IVF-conceived children's size disappear by adolescence

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856